TY - JOUR
T1 - A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin β-subunit gene
AU - Bodenner, D. L.
AU - Mroczynski, M. A.
AU - Weintraub, B. D.
AU - Radovick, S.
AU - Wondisford, F. E.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1991
Y1 - 1991
N2 - The first exon of the human thyrotropin-β (hTSHβ) gene has been demonstrated in our laboratory to contain a major thyroid hormone inhibitory element. In order to characterize fully this element, we have performed a detailed functional and structural scanning mutational analysis of this element. Various -1192 to +37 (base pairs) bp fragments of the hTSHβ gene containing consecutive five deoxythymidine substitution mutations of the first exon were inserted into a luciferase reporter plasmid and transiently transfected into human embryonal cells (293) and stably transfected into rat pituitary cells (GH3). Two domains (domain 1 and 2) were identified by scanning mutations that were essential for function of the thyroid hormone inhibitory element: +3 to +13 bp and +28 to +37 bp. Biotinylated DNA fragments containing -12 to +43 bp of the hTSHβ gene and the identical scanning mutations demonstrate that in vitro synthesized c-erbA-β binding is disrupted as much as 95% by mutations from -3 to +17 bp and to a lesser extent (20-30%) by mutations from +23 to +27 bp and from +33 to +43 bp. Domain 1 displayed a higher affinity for c-erbA-β than domain 2 in avidin-biotin complex DNA-binding and gel-mobility assays. Using increasing amounts of in vitro synthesized c-erbA-β, we were unable to demonstrate more than one protein-DNA complex in gel-mobility assays. However, using the avidin-biotin complex DNA-binding assay and the cross-linking reagent, 1,6-bismaleimidohexane, we were able to demonstrate thyroid hormone receptor dimer formation on domain 1 but not to any significant extent on domain 2. In conclusion, functional and DNA-binding studies suggest that the thyroid hormone receptor binds to two distinct regions in the first exon of the hTSHβ gene. The upstream site (domain 1) binds c-erbA-β with higher affinity and is capable of binding c-erbA-β as a dimer under some conditions, while the downstream site (domain 2) appears to bind a single molecule of c-erbA-β with lower affinity. These results suggest that thyroid hormone receptor, binding to at least two sites in the first exon, act in conjunction to mediate T3 inhibition of hTSHβ expression.
AB - The first exon of the human thyrotropin-β (hTSHβ) gene has been demonstrated in our laboratory to contain a major thyroid hormone inhibitory element. In order to characterize fully this element, we have performed a detailed functional and structural scanning mutational analysis of this element. Various -1192 to +37 (base pairs) bp fragments of the hTSHβ gene containing consecutive five deoxythymidine substitution mutations of the first exon were inserted into a luciferase reporter plasmid and transiently transfected into human embryonal cells (293) and stably transfected into rat pituitary cells (GH3). Two domains (domain 1 and 2) were identified by scanning mutations that were essential for function of the thyroid hormone inhibitory element: +3 to +13 bp and +28 to +37 bp. Biotinylated DNA fragments containing -12 to +43 bp of the hTSHβ gene and the identical scanning mutations demonstrate that in vitro synthesized c-erbA-β binding is disrupted as much as 95% by mutations from -3 to +17 bp and to a lesser extent (20-30%) by mutations from +23 to +27 bp and from +33 to +43 bp. Domain 1 displayed a higher affinity for c-erbA-β than domain 2 in avidin-biotin complex DNA-binding and gel-mobility assays. Using increasing amounts of in vitro synthesized c-erbA-β, we were unable to demonstrate more than one protein-DNA complex in gel-mobility assays. However, using the avidin-biotin complex DNA-binding assay and the cross-linking reagent, 1,6-bismaleimidohexane, we were able to demonstrate thyroid hormone receptor dimer formation on domain 1 but not to any significant extent on domain 2. In conclusion, functional and DNA-binding studies suggest that the thyroid hormone receptor binds to two distinct regions in the first exon of the hTSHβ gene. The upstream site (domain 1) binds c-erbA-β with higher affinity and is capable of binding c-erbA-β as a dimer under some conditions, while the downstream site (domain 2) appears to bind a single molecule of c-erbA-β with lower affinity. These results suggest that thyroid hormone receptor, binding to at least two sites in the first exon, act in conjunction to mediate T3 inhibition of hTSHβ expression.
UR - http://www.scopus.com/inward/record.url?scp=0025837137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025837137&partnerID=8YFLogxK
M3 - Article
C2 - 1657975
AN - SCOPUS:0025837137
SN - 0021-9258
VL - 266
SP - 21666
EP - 21673
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 32
ER -